Vivek Ramaswamy
- Auteur
Vivek Ramaswamy is a successful entrepreneur who has founded multiple successful enterprises. A first-generation American, he is the founder and Executive Chairman of Roivant Sciences, a new type of biopharmaceutical company focused on the application of technology to drug development. He founded Roivant in 2014 and led the largest biotech IPOs of 2015 and 2016, eventually culminating in successful clinical trials in multiple disease areas that led to FDA-approved products.
Mr. Ramaswamy was born and raised in southwest Ohio. He graduated summa cum laude in Biology from Harvard in 2007 and began his career as a successful biotech investor at a prominent hedge fund.
Mr. Ramaswamy was born and raised in southwest Ohio. He graduated summa cum laude in Biology from Harvard in 2007 and began his career as a successful biotech investor at a prominent hedge fund.
Vivek Ramaswamy is a successful entrepreneur who has founded multiple successful enterprises. A first-generation American, he is the founder and Executive Chairman of Roivant Sciences, a new type of biopharmaceutical company focused on the application of technology to drug development. He founded Roivant in 2014 and led the largest biotech IPOs of 2015 and 2016, eventually culminating in successful clinical trials in multiple disease areas that led to FDA-approved products.
Mr. Ramaswamy was born and raised in southwest Ohio. He graduated summa cum laude in Biology from Harvard in 2007 and began his career as a successful biotech investor at a prominent hedge fund. Mr. Ramaswamy continued to work as an investor while earning his law degree at Yale, where he was a recipient of the Paul & Daisy Soros Fellowship for New Americans.
Mr. Ramaswamy was featured on the cover of Forbes magazine in 2015 for his work in drug development. In 2020 he emerged as a prominent national commentator on stakeholder capitalism, free speech, and woke culture. He has authored numerous articles and op-eds, which have appeared in the Wall Street Journal, National Review, Newsweek, and Harvard Business Review.
Mr. Ramaswamy serves on the board of directors of the Philanthropy Roundtable and the Foundation for Research on Equal Opportunity.
Mr. Ramaswamy was born and raised in southwest Ohio. He graduated summa cum laude in Biology from Harvard in 2007 and began his career as a successful biotech investor at a prominent hedge fund. Mr. Ramaswamy continued to work as an investor while earning his law degree at Yale, where he was a recipient of the Paul & Daisy Soros Fellowship for New Americans.
Mr. Ramaswamy was featured on the cover of Forbes magazine in 2015 for his work in drug development. In 2020 he emerged as a prominent national commentator on stakeholder capitalism, free speech, and woke culture. He has authored numerous articles and op-eds, which have appeared in the Wall Street Journal, National Review, Newsweek, and Harvard Business Review.
Mr. Ramaswamy serves on the board of directors of the Philanthropy Roundtable and the Foundation for Research on Equal Opportunity.
Boeken van Vivek Ramaswamy
Vivek Ramaswamy
Capitalist Punishment
A Wall Street cartel has quietly seized control of the American economy, and they are forcing governments and businesses to bow down to their political agenda—using your money to do it.
Meer
Vivek Ramaswamy
Nation of Victims
The New York Times bestselling author of Woke Inc. and a 2024 presidential candidate makes the case that the essence of true American identity is to pursue excellence unapologetically and reject victimhood culture.
Meer
Vivek Ramaswamy
Woke, Inc.
A young entrepreneur makes the case that politics has no place in business, and sets out a new vision for the future of capitalism.
Meer
Interviews en artikelen (1)
achtergrond
De vloek van Big Tech
| 20 januari 2025
Vandaag trekt Donald J. Trump voor de tweede keer het Witte Huis in. De weken daarvoor werd duidelijk wie welk departement krijgt. Onder zijn dikke loyalisten zitten naast presentatoren, familie en CEO’s dit keer selfmade men uit de Tech industrie.
